...nalógica numérica para a secura passou de 6,38 (2,14) para 5,85 (2,57) no grupo placebo e de 6,53 (1,97) para 6,22 (1,87) no grupo de hidroxicloroquina. A média (Desvio Padrão) do escore da escala analógica numérica de dor passou de 4,92 (2,94) para 5,08 (2,48) no grupo placebo e 5,09 (3,06) para 4,59 (2,90) no grupo de hidroxicloroquina. A escala média (Desvio Padrão) para a escala analógica numé......
...brief intervention. Arthritis Rheum 2002;46:347–56. 57. O’Dell JR, Leff R, Paulsen G, et al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002;46:1164–70. 58. Grigor C, Capell H, Stirling A, ......
...s. ACP Medicine. 2012. [The original English language work has been published by DECKER INTELLECTUAL PROPERTIES INC. Hamilton, Ontario, Canada. Copyright © 2015 Decker Intellectual Properties Inc. All Rights Reserved.] Tradução: Paulo Henrique Machado Revisão técnica: Dr. Lucas Santos Zambon As doenças do espectro da esclerodermia formam um grupo heterogêneo de distúrbios que são ......
...h excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29:62–7. 4. Andonopoulos AP, Skopouli FN, Dimou GS, et al. Sjögren’s syndrome in systemic lupus erythematosus. J Rheumatol 1990;17:201–4. 5. Nossent JC, Swaak AJ. Systemic lupus erythematosus VII: frequency and impact of secondary Sjögren’s syndrome. Lupus 1998;7:231......